Sensitivity of Cyclic Alternating Pattern to Prolonged Pharmacotherapy

Università degli studi di Parma, Parma, Emilia-Romagna, Italy
Clinical Neuropharmacology (Impact Factor: 2.01). 10/1997; 20(5):447-54. DOI: 10.1097/00002826-199710000-00010
Source: PubMed


To test the effects of a hypnotic drug administered on a regular basis, six adults (four women and two men; mean age 37 years) who complained of transient or short-term insomnia, took zolpidem 10 mg at bedtime for 4 consecutive weeks. The period of active treatment, preceded by a baseline placebo night, ended with a 4-night gradual tapering phase followed by 3 nights of placebo administration. After adaptation to the sleep laboratory, all subjects underwent five polysomnographic recordings; baseline placebo (night 1); 1st, 7th and 28th nights of hypnotic medication (nights 2, 3, and 4 respectively); 3rd placebo night after complete tapering (night 5) and completed a morning visual analogue scale (VAS) for evaluating sleep quality. The sleep recordings were scored according to the conventional procedures (macrostructure) and to the cyclic alternating pattern (CAP) rules (microstructure). Data analysis was based on a repeated-measures analysis of variance integrated by post-hoc comparisons. At the macrostructural level, significant overall modifications (p < 0.035) emerged only from slow-wave sleep (SWS). The amounts of SWS were enhanced along the entire drug period, but a significant difference was found only between the baseline night (10%) and the first night of drug administration (20%). At the microstructural level, CAP rate (the ratio of CAP time to non-rapid eye movement sleep time) showed overall significant variations throughout the entire protocol period (p < 0.0001). Compared with baseline night 1 (59%), the CAP rate was significantly lower on drug nights 2 (32%), 3 (37%), and 4 (38%). The increase in the CAP rate found on night 5 (43%) was still significantly below the baseline value. The VAS scores showed significant overall changes (p < 0.0001), with improved values during the active treatment period.

2 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: La douleur est une cause majeure de l'insomnie chez les malades et plus de 70% des patients en douleur se plaignent de troubles du sommeil. Des études polysomnographiques ont démontré que les patients éprouvant de la douleur chronique affichent une perturbation marquée de la structure et de la continuité du sommeil. Les constatations les plus courantes sont: changements fréquents de phases de sommeil, augmentation des réveils nocturnes, diminution du sommeil à ondes lentes et du sommeil à mouvements oculaires rapides, augmentation du sommeil superficiel et des mouvements du corps, intrusion électroencéphalographique (EEG) de sommeil alpha-delta, augmentation du nombre d'éveils et du taux de pattern d'activation cyclique (PAC). Le PAC est un marqueur physiologique du sommeil instable qui amplifie les réactions aux événements perturbateurs de la consolidation du sommeil. Ainsi, la qualité du sommeil dépend de mécanismes cérébraux qui évaluent les événements externes afin de protéger l'intégrité vitale. Ces mécanismes, situés au niveau thalamique, commande le maintien du sommeil, l'éveil bref ou le réveil comportemental, selon le risque que représente l'événement en cause. Pendant le sommeil, le système neurovégétatif demeure réceptif aux stimuli externes et opère en synchronie avec le processus PAC. Chez les sujets sains, la stimulation thermique nociceptive provoque une accélération du rythme cardiaque peu importe la phase du sommeil, avec un gradient décroissant de la phase 2 au sommeil à ondes lentes et au sommeil MOR. Les réponses autonomiques peuvent varier chez les patients fibromyalgiques n'affichant pas la diminution normale de l'activité sympathique pendant le sommeil et chez les patients éprouvant de la douleur chronique qui sont déjà aux prises avec la fragmentation du sommeil ou l'insomnie. Les modifications spécifiques du sommeil découlant d'un syndrome unique de douleur ou de parasomnies associées à la douleur pendant le sommeil (par ex. le bruxisme, les crampes nocturnes dans les jambes et le reflux gastro-œsophagien) sont également décrites. Pain is reported as a leading cause of insomnia in medical illness and more than 70% of patients with painful syndromes complain of sleep problems. Polysomnographic investigation has demostrated that patients with chronic pain have a marked alteration of sleep structure and continuity. The most common findings are: frequent stage shifts, increase of nocturnal awakenings, decreased amounts of slow wave sleep and REM sleep, increase of superficial sleep and body movements, intrusion of alpha-delta sleep, increased arousals and CAP rate. CAP (cyclic alternating pattern) is the EEG marker of unstable sleep and is enhanced by any factor or event that interferes with sleep consolidation. The maintenance of sleep relies on cerebral mechanisms that evaluate sensorial inputs, prevent awakening for non-meaningful information and protect vital integrity allowing relevant inputs to trigger arousals or other behavioural responses. These safeguarding processes require a gate for sensory inputs. Gating is exerted at the thalamic level, leading the cortex to be awakened, aroused or maintain sleep continuity in relation to the intensity and risk of the stimulus and to the ongoing condition of sleep depth and stability. During sleep, the neurovegetative system remains active to external stimuli and proceeds in synchrony with the CAP process. In healthy subjects, a significant cardiac acceleration provoked by nociceptive thermal stimulation occurs during all sleep stages with a decreasing gradient from stage 2, slow wave sleep and REM sleep. Autonomic responses may vary in fibromyalgic patients without the normal decrease in sympathetic activity during sleep and in chronic pain patients already affected by sleep fragmentation or insomnia. The specific alterations of sleep in single painful syndromes and in parasomnias associated with pain during sleep (such as bruxism, nocturnal leg cramps and gastrœsophageal reflux) are described.
    Douleur et Analgésie 06/2003; 16(2):71-78. DOI:10.1007/BF03007106 · 0.09 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The present study aimed at offering a standardized database for cyclic alternating pattern (CAP) parameters across representative ages of life. CAP parameters were quantified in 40 healthy sleepers and polygraphically investigated in a partially sound-proof recording chamber under a standard laboratory setting. Four age groups were investigated (teenagers: 10-19 years; young adults: 20-39 years; middle-aged: 40-59 years; elderly: 60 years). Each group included 10 subjects (5 males and 5 females). Nocturnal recordings were accomplished after adaptation to the sleep laboratory that also served to rule out the presence of sleep-related disorders. The study indicated that CAP is a natural phenomenon of NREM sleep, with specific age-related characteristics across the life cycle. CAP rate in NREM sleep, defined as the percentage ratio of total CAP time to total NREM sleep time, showed a U-shape profile with minimum in young adults (31.9%), maximum in the elderly group (55.3%), and intermediate values in teenagers (43.4%) and in middle-aged subjects (37.5%). The longest duration of CAP cycles was found among the older subjects (31 s). The highest amounts of subtypes A1 were identified in teenagers (n = 261), while the highest amounts of A2 and A3 subtypes occurred in the elderly group (n = 183). Across the ages, the level of arousal mostly fluctuated in stages 1 and 3, whereas stage 4 emerged as the most stable NREM stage. Overall, stage 2 better reflected the CAP values referred to as total NREM sleep. The periodic arousal fluctuations reflected by CAP are a natural phenomenon of NREM sleep with specific age-related variations across the life cycle.
    Electroencephalography and Clinical Neurophysiology 01/1999; 107(6):439-50. DOI:10.1016/S0013-4694(98)00108-4
Show more